Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
| Website | http://www.mesentech.com |
| Revenue | $5 million |
| Employees | 9 (4 on RocketReach) |
| Founded | 2018 |
| Address | 2222 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, CA |
| Phone | (778) 231-2500 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical, Therapeutics |
| Competitors | Twilio, RingCentral, Vonage, Infobip, Sinch, Telesign, Telnyx, Plivo, ZENVIA, ClickSend +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Mesentech employee's phone or email?
Mesentech Questions
The Mesentech annual revenue was $5 million in 2026.
Gang Chen is the Director of Medicinal Chemistry of Mesentech.
4 people are employed at Mesentech.
Mesentech is based in Vancouver, British Columbia.
The NAICS codes for Mesentech are [325, 3254, 32541, 32].
The SIC codes for Mesentech are [283, 28].
Top Mesentech Employees
Related Companies
